Found: 30
Select item for more details and to access through your institution.
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1933, doi. 10.1038/leu.2013.90
- By:
- Publication type:
- Article
Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1943, doi. 10.1038/leu.2013.179
- By:
- Publication type:
- Article
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1910, doi. 10.1038/leu.2013.64
- By:
- Publication type:
- Article
RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1793, doi. 10.1038/leu.2013.200
- By:
- Publication type:
- Article
Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1913, doi. 10.1038/leu.2013.67
- By:
- Publication type:
- Article
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1870, doi. 10.1038/leu.2013.122
- By:
- Publication type:
- Article
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1920, doi. 10.1038/leu.2013.79
- By:
- Publication type:
- Article
Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1926, doi. 10.1038/leu.2013.82
- By:
- Publication type:
- Article
Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1930, doi. 10.1038/leu.2013.85
- By:
- Publication type:
- Article
Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1939, doi. 10.1038/leu.2013.112
- By:
- Publication type:
- Article
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1813, doi. 10.1038/leu.2013.140
- By:
- Publication type:
- Article
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1940, doi. 10.1038/leu.2013.144
- By:
- Publication type:
- Article
Mutations and prognosis in primary myelofibrosis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1861, doi. 10.1038/leu.2013.119
- By:
- Publication type:
- Article
AKT is a therapeutic target in myeloproliferative neoplasms.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1882, doi. 10.1038/leu.2013.167
- By:
- Publication type:
- Article
Age, JAK2<sup>V617F</sup> and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1826, doi. 10.1038/leu.2013.120
- By:
- Publication type:
- Article
Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1936, doi. 10.1038/leu.2013.92
- By:
- Publication type:
- Article
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1874, doi. 10.1038/leu.2013.163
- By:
- Publication type:
- Article
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1852, doi. 10.1038/leu.2013.133
- By:
- Publication type:
- Article
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1949, doi. 10.1038/leu.2013.190
- By:
- Publication type:
- Article
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1917, doi. 10.1038/leu.2013.77
- By:
- Publication type:
- Article
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1803, doi. 10.1038/leu.2013.173
- By:
- Publication type:
- Article
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1923, doi. 10.1038/leu.2013.81
- By:
- Publication type:
- Article
Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1820, doi. 10.1038/leu.2013.117
- By:
- Publication type:
- Article
Toll-like receptor alterations in myelodysplastic syndrome.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1832, doi. 10.1038/leu.2013.180
- By:
- Publication type:
- Article
Mobilization studies in C3-deficient mice unravel the involvement of a novel crosstalk between the coagulation and complement cascades in mobilization of hematopoietic stem/progenitor cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1928, doi. 10.1038/leu.2013.84
- By:
- Publication type:
- Article
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1891, doi. 10.1038/leu.2013.186
- By:
- Publication type:
- Article
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1902, doi. 10.1038/leu.2013.95
- By:
- Publication type:
- Article
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1841, doi. 10.1038/leu.2013.193
- By:
- Publication type:
- Article
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1946, doi. 10.1038/leu.2013.182
- By:
- Publication type:
- Article